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Inhibition of Prostaglandin E2 Production by Anti-inflammatory
Hypericum perforatum Extracts and Constituents in RAW264.7
Mouse Macrophage Cells
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PHILIP M. DIXON,†,⊥ KATHLEEN DELATE,†, PATRICIA A. MURPHY,†,§
EVE S. WURTELE,†,‡,# AND DIANE F. BIRT*,†,‡,§
The Center for Research on Botanical Dietary Supplements, Interdepartmental Genetics Graduate
Program, Department of Food Science and Human Nutrition, Department of Genetics, Development,
and Cell Biology, Department of Horticulture, Department of Agronomy, and Department of Statistics,
Iowa State University, Ames, Iowa 50011
Hypericum perforatum (Hp) is commonly known for its antiviral, antidepressant, and cytotoxic
properties, but traditionally Hp was also used to treat inflammation. In this study, the anti-inflammatory
activity and cytotoxicity of different Hp extractions and accessions and constituents present within
Hp extracts were characterized. In contrast to the antiviral activity of Hp, the anti-inflammatory activity
observed with all Hp extracts was light-independent. When pure constituents were tested, the
flavonoids, amentoflavone, hyperforin, and light-activated pseudohypericin, displayed anti-inflammatory
activity, albeit at concentrations generally higher than the amount present in the Hp extracts.
Constituents that were present in the Hp extracts at concentrations that inhibited the production of
prostaglandin E2 (PGE2) were pseudohypericin and hyperforin, suggesting that they are the primary
anti-inflammatory constituents along with the flavonoids, and perhaps the interactions of these
constituents and other unidentified compounds are important for the anti-inflammatory activity of the
Hp extracts.
KEYWORDS: Hypericum perforatum; St. John’s wort; hyperforin; hypericin; pseudohypericin; quercetin;
flavonoids; anti-inflammatory; cytotoxicity; PGE2; RAW264.7
INTRODUCTION
Hypericum perforatum (Hp) is an herbaceous perennial plant
native to Europe and Asia (1). Traditionally, Hp extracts were
used both externally, for the treatment of inflammation, wounds,
and skin diseases, and internally, for the treatment of anxiety,
headache, bedwetting, neuralgia, inflammation, and mild-to-
moderate depression (2). The use of Hp supplements has been
prevalent for many years, but increased use of these supplements
and the identification of bioactive constituents present within
Hp have intensified interest in the mechanisms by which Hp
extracts exert specific bioactivities, such as inhibiting inflam-
mation.
Hp extracts possess anti-inflammatory properties in a variety
of in vivo systems. The cyclooxygenase (COX) enzymes
metabolize arachidonic acid to eicosanoids. The products of
COX-2 metabolism of arachidonic acid are the 2-series pros-
tanoids, of which prostaglandin E2 (PGE2) is important in
mediating pain, inflammation, and swelling (3). Raso et al. found
that 100 mg/kg by gavage of Hp root dry powder extract twice
daily significantly inhibited COX-2 protein levels and signifi-
cantly reduced carrageenan-induced paw edema in mice (4).
Herold et al. reported that a hydroalcoholic Hp extract signifi-
cantly inhibited 5-lipoxygenase but did not affect COX-2 protein
in cell-free systems (5). Mice fed 50-300 mg/kg Hp extract
by gavage showed a dose-related and significant inhibition of
carrageenan-induced paw edema (6). A 50% ethanol Hp extract
administered at both 100 and 200 mg/kg reduced inflammation
and analgesia in carrageenan-induced paw edema and cotton
pellet-induced granuloma (7), and an Hp extract suppressed
inflammatory and leukocyte infiltration in carrageenan- and
prostaglandin E1-induced Wistar rats (8).
The minimal dose of Hp to provide a therapeutic effect is
unknown; however, Hp treatments for humans generally range
from 500 to 650 mg/day and vary depending upon study design
(9). Others report that the dosage for a fluid or powder extract
would be the amount of extract equivalent to 0.5-3.0 mg of
hypericin and pseudohypericin daily (2). Relatively few studies
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have determined the levels of many constituents present in
plasma after administration of Hp extracts. Schulz et al.
administered 612 mg of dry Hp extract to 18 healthy male
volunteers as a single oral dose for 14 days. The maximal plasma
concentrations for hypericin, pseudohypericin, and quercetin
were 3.14, 8.5, and 47.7 ng/mL, respectively (10).
The bioactive constituents of Hp extracts are complex and
include many different classes of chemicals (11). Two of these
classes of constituents are present in only select plant species:
naphthodianthrones such as hypericin and pseudohypericin and
phloroglucinols like hyperforin (11). Other classes of constitu-
ents present within Hp are also present in many plant species;
these include the flavonoids and biflavonoids, tannins, procya-
nidins, and caffeic acid derivatives, among others. The fla-
vonoids present in Hp are quercetin, the aglycone form, and its
glycosylated derivatives, quercitrin, isoquercitrin, hyperoside,
and rutin, whereas a biflavonoid present in Hp is I3′,II8-
biapigenin, also known as amentoflavone.
Although individual constituents have been shown to provide
bioactivity alone, the interaction among constituents may
account for diverse bioactivities of the supplements. Work by
Schmitt et al. supports the role of unknown compounds in the
bioactivity of Hp extracts in which chlorogenic acid and
porphyrin, which were present in Hp extracts, attenuated
hypericin’s light-dependent toxicity in HaCaT keratinocytes
extracts (12, 13).
Because comprehensive research on the anti-inflammatory
activity of Hp is lacking, to begin to identify anti-inflammatory
constituents we hypothesized that Hp extracts made using
several extraction procedures and accessions would yield distinct
chemical profiles which could be related to the anti-inflamma-
tory activity of the Hp extracts. The goal of this study was to
identify Hp extracts from different extraction procedures and
Hp accessions that maximize anti-inflammatory activity in
RAW264.7 macrophage cells. To assess which constituents may
be responsible for the anti-inflammatory activity seen in the
extracts, constituents known to be present within Hp were also
tested. Because Hp extracts are known to possess cytotoxic
properties, the cytotoxicity of these Hp extracts and constituents
was assessed. The dependence of the anti-inflammatory activity
on light activation of Hp extracts, a treatment condition
important for several Hp bioactivities, was also evaluated.
MATERIALS AND METHODS
Plant Material and Extractions. All plant material was obtained
from either Frontier Natural Products Co-op (FNPC) (Norway, IA) or
the North Central Regional Plant Introduction Station (NCRPIS) (Ames,
IA) of the U.S. Department of Agriculture and processed as described
in Schmitt et al. (12). Six accessions of Hp were provided by the
NCRPIS: Plant Introductions (PI) 325351 and 371528 and the
commercial varieties, Common, ‘Medizinal’ (Elixir) (Ames 27452),
‘Helos’ (Ames 27453), and ‘Topas’ (Ames 27455). Accessions PI
325351 and 371528 were collected in the former Soviet Union;
Common was grown from seeds supplied by Johnny’s Selected Seeds
(Winslow, ME), and the other varieties were grown from seeds supplied
by Richter’s Herb Specialists (Goodwood, ON, Canada). ‘Topas’, bred
to increase overall commercial production, was developed in Germany,
and Elixir, bred to contain a higher amount of napthodianthrones, and
‘Helos’, bred for tolerance to anthracnose disease, were developed in
Denmark (14, 15).
Six grams of dried plant material was extracted by either Soxhlet
extraction for 6 h or room temperature shaking for 24 h, evaporated to
dryness, and dissolved in 15 mL of dimethyl sulfoxide (DMSO) (Sigma,
St. Louis, MO) as described previously (12). Extracts were stored at
-30 °C in the dark and used as stock solutions for treatments. Because
preliminary testing determined that the highest amount of DMSO that
could be added onto the cells was 0.1% of the media and because the
Hp extracts were dissolved in DMSO, each stock extract was added at
a final DMSO concentration of 0.1% of the media that was added onto
the RAW264.7 cells for an initial test of anti-inflammatory activity.
Thus, the extracts were initially compared at different (íg/mL)
concentrations on the basis of adding 0.1% DMSO to allow comparison
of the relative anti-inflammatory activity of the constituents extracted
from 6 g of dried plant material. Hp extracts screened in this way will
be referred to as “highest concentration tested” in this paper. The stock
extract was further diluted in DMSO to allow for comparisons of the
extracts at the same (íg/mL) concentration.
Endotoxin levels of the plant extracts were assayed using the Limulus
Amebocyte Lysate Test (BioWhittaker, Inc., Walkersville, MD) because
the presence of high levels of endotoxin in the extracts would stimulate
the macrophages to release inflammatory mediators including PGE2.
Endotoxin levels ranged from 0.001 to 0.2 endotoxin units per milliliter
(EU/mL). Because the extracts are further diluted in media, the range
of endotoxin levels present in the RAW264.7 macrophage cell media
was 0.000001-0.0002 EU/mL. Pure endotoxin up to 5 EU/mL did not
significantly increase the RAW264.7 cells’ production of PGE2 in the
assay (data not shown).
Chemicals. Hypericin was purchased from Molecular Probes
(Eugene, OR) and pseudohypericin from Calbiochem-Novabiochem (La
Jolla, CA). Chlorogenic acid, quercetin, hyperoside, hyperforin, and
rutin were purchased from Fisher Scientific (Hanover Park, IL), and
quercitrin, isoquercitrin, and amentoflavone were purchased from
ChromaDex (Santa Ana, CA).
Cell Culture. RAW264.7 macrophages were purchased from the
American Type Culture Collection (ATCC; Manassas, VA) and cultured
in high-glucose Dulbecco’s Modified Eagle’s medium (4500 mg/L
D-glucose) (Invitrogen, Carlsbad, CA) and supplemented with 100 IU/
mL penicillin/streptomycin (Invitrogen) and 10% fetal bovine serum
(FBS) (Invitrogen). Cells were maintained in a 5% CO2 incubator with
70% humidity at 37 °C until 70% confluent in 75 cm2 flasks.
Cell Treatments. Cells were plated at a density of 1.0  105 cells/
well in 24-well cell culture plates and allowed to attach overnight. Cells
were incubated with or without 1 íg/mL lipopolysaccharide (LPS)
(Escherichia coli 02B:B6) (Sigma) and solvent alone, DMSO, or plant
extract or constituent simultaneously for 8 h. DMSO concentration did
not exceed 0.1% of the media, an amount determined by preliminary
testing. Four controls were included in each treatment: media alone,
media and DMSO, media and LPS, and media and LPS and DMSO.
In addition, 10 íM quercetin and 6 íM baicalien were used as positive
controls to ensure the assay was working properly.
After initial testing of FNPC plant material in ambient light, the
anti-inflammatory and cytotoxicity screening was always performed
in both light-activated and dark conditions, due to the well-known light-
activated properties of the naphthodianthrone compounds present within
the Hp extracts. Experimental conditions for light activation were as
previously described (12). Cell supernatants were collected on ice and
stored in a -70 °C freezer for use in the PGE2 assay as described below.
PGE2 Assay. The supernatant samples were assayed with a Pros-
taglandin E2 EIA kit (GE Biosciences, Piscataway, NJ) according to
the manufacturer’s instructions. Supernatants were diluted 1:15 in water
to ensure the concentrations of PGE2 present within the samples were
within the linear range of the standard curve for the assay.
Cytotoxicity Assay. CellTiter96 Aqueous One Solution cell prolif-
eration assay (Promega Corp., Madison, WI) was used as previously
described in Schmitt et al. with an 8 h treatment incubation to parallel
the anti-inflammatory studies (12). Following the 8 h incubation,
treatment solutions were removed and fresh media and CellTiter96 dye
were added for 3 h and 15 min (12). The metabolized dye solutions
were transferred to 96-well plates for absorbance measurement at 490
nm. The number of viable cells for each treatment was compared to
the media + DMSO solvent control. Light-activated and dark treatments
of 20 íM hypericin were used as positive controls to ensure the assay
was working properly.
LC-MS-UV Analysis. Samples in DMSO were diluted 1:2 with
methanol prior to injection into an Agilent Technologies 100 ion trap
liquid chromatography-electron spray ionization-mass spectrometer,
with a coupled UV absorption detector (LC-MS-UV). Standards were
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injected in triplicate for each concentration, and extracts were injected
in duplicate. A Synergi Max-RP 150  4.6 mm column (Phenomenex,
Torrance, CA) was used for analytical separation. For the mobile phase
an acetonitrile/methanol (ACN/MeOH) 9:1 v/v (A) and 10 mM
ammonium acetate (B) gradient was used. The gradient consisted of
85% A/15% B in 10 min to 80% A/20% B, then to 100% B in 25 min
and held for 5 min at 40 °C. The flow rate was 0.75 mL/min (16).
External calibration curves for standards were constructed from coupled
UV absorption data at 254 nm.
Concentrated stock Hp extracts were analyzed by LC-MS-UV, and
calculations were made to estimate the concentration of constituents
present in the amount of Hp extract used as a treatment at the highest
concentration tested. The data are presented in this way for comparison
between the amount of constituents needed to observe an effect and
the amount of constituent that would be present in the Hp extracts when
tested at the highest concentration.
Statistical Analysis. The anti-inflammatory data were logarithmically
transformed to eliminate unequal variances and skewed distribution.
An F-protected two-way ANOVA was used followed by a Tukey-
Kramer test for multiple comparisons for all PGE2 samples (17). For
the anti-inflammatory data in the tables, the data are shown as mean
percent reduction in LPS-induced PGE2 levels ( the 95% confidence
interval as compared to the media + LPS + DMSO control. For the
anti-inflammatory data presented in the figures, original PGE2 levels
( standard error are shown and statistical significance was determined
by an F-protected two-way ANOVA followed by a Tukey-Kramer
test for multiple comparisons as compared to the media + LPS +
DMSO control. For cytotoxicity, data are presented as mean percent
reduction in cell viability ( standard error, and the p value was adjusted
using the Dunnett-Hsu method for multiple comparisons against the
media + DMSO control (18). To determine light versus dark differ-
ences, the data were compared using the Tukey-Kramer test for
multiple comparisons. For LC-MS-UV detection of compounds in
NCRPIS Hp extracts, data are presented as mean ( standard error,
and differences in concentrations of constituents for each extract were
determined using a one-way ANOVA for each constituent followed
by a Tukey-Kramer test. p values of <0.05 were considered to be
statistically significant.
RESULTS
Anti-inflammatory Activity of Extracts of FNPC Hp Plant
Material Prepared by Different Extraction Procedures. To
determine the relative bioactivity of material within the Hp
extracts made by different extraction procedures, an initial screen
was conducted using the FNPC Hp extracts. None of the extracts
made from FNPC plant material significantly reduced PGE2
levels when added to the media without LPS (data not shown).
Soxhlet extracts generally reduced LPS-induced PGE2 levels
greater than room temperature extracts (room temperature
extracts not shown), and all of the Soxhlet extracts significantly
reduced PGE2 levels at the highest concentration tested (Table
1). Although the HPLC analysis suggested that the Soxhlet and
room temperature extracts had similar chemical profiles, the
Soxhlet method extracted more plant material than the room
temperature shaking method (12). Only the room temperature
70% ethanol (-chloroform) extract tested at 65 íg/mL signifi-
cantly reduced LPS-induced PGE2 levels by 66%. The other
room temperature extracts tested [70% ethanol, chloroform,
hexane, and 70% ethanol (-hexane)] reduced LPS-induced
PGE2 levels from 0 to 46% at concentrations ranging from 6 to
74 íg/mL. Although the Soxhlet hexane extract caused the
greatest reduction in LPS-induced PGE2 levels (81%) at the
lowest concentration (17 íg/mL) tested in the screening among
the Soxhlet FNPC extracts, Soxhlet chloroform and Soxhlet
ethanol extracts were used for the remaining studies for two
reasons. First, ethanol extracts are used primarily in the
supplement industry, and, second, chloroform extracts do not
contain the light-activated hypericin and pseudohypericin
compounds, which allows for determination of the anti-
inflammatory nature of other compounds in the extract under
light-activated and dark treatment conditions.
The cytotoxicity of the FNPC Hp extracts was reported in
Schmitt et al. (12). All of the ethanol and chloroform extracts
and the Soxhlet hexane extract possessed significant cytotoxicity
against NIH3T3 mouse fibroblasts, SW480 human colon cancer
cells, and HaCaT human keratinocytes. The concentrations of
the extracts tested in Schmitt et al. (12) were higher than those
used in the initial anti-inflammatory screen due to the greater
sensitivity of RAW264.7 macrophage cells to DMSO.
Quantification of Constituents Present within NCRPIS Hp
Plant Material Extracts. The NCRPIS Soxhlet ethanol and
chloroform extracts were characterized by LC-MS-UV for
detection of 10 known constituents present within the extracts.
Chlorogenic acid was one of the most abundant constituents
detected in the accessions (Table 2). Higher levels of chloro-
genic acid were observed for Soxhlet ethanol Common, ‘Helos’,
and Elixir than PI 325351, PI 371528, and ‘Topas’. Rutin was
the most abundant flavonoid detected in all accessions. Higher
levels of rutin were observed for Soxhlet ethanol Common, PI
325351, ‘Helos’, PI 371528, ‘Topas’, and Elixir than ‘Topas’
and PI 371528. Levels of hyperforin, isoquercitrin, hyperoside,
quercitrin, amentoflavone, hypericin, and pseudohypericin in
the Soxhlet ethanol extracts differed among the accessions. Very
few constituents were detected in the Soxhlet chloroform
extracts, but hyperforin was the most abundant. Quercitrin was
detected in the Soxhlet chloroform Common and ‘Helos’
extracts, amentoflavone was detected in the Soxhlet chloroform
Common, ‘Helos’, and ‘Topas’ extracts, and hypericin was
detected in the Soxhlet chloroform Elixir extract.
Anti-inflammatory Activity and Cytotoxicity of NCRPIS
Hp Accession Extracts. An initial screen was conducted using
the NCRPIS Soxhlet ethanol and chloroform Hp accession
extracts at the concentration extracted from 6 g of dried plant
material. None of the extracts significantly reduced the level
of PGE2 produced without LPS (data not shown). No differences
between light-activated and dark treatments were observed, and
data were pooled across this variable for presentation. The
accession Elixir (8 íg/mL) Soxhlet chloroform extract reduced
LPS-induced PGE2 levels (43% reduction) at the lowest
concentration observed in this screening (Table 3). All Soxhlet
Table 1. Anti-inflammatory Activity of Extracts of FNPC Hp Plant
Material Prepared by Different Soxhlet Extraction Procedures of Dried
Hp and Tested at Concentrations That Represent the Relative Amount
Extracted from 6 g of Plant Material
Soxhlet extraction
[íg/mL]
testeda
% reduction in
LPS-induced
PGE2b (95% CI)
70% ethanol 116 78 (64−87)**
chloroform 43 79 (64−87)**
hexane 17 81 (61−91)**
70% ethanol (−hexane) 65 73 (55−84)**
70% ethanol(−chloroform) 69 82 (62−91)**
a Concentration tested in íg/mL represents the final concentration of the extract
in the media. Anti-inflammatory activity [b mean percent reduction in LPS-induced
PGE2 levels as compared to media + LPS + DMSO control (95% confidence
intervals)] was screened using the PGE2 assay (n ) 4 for each) in ambient light.
Addition of LPS to the culture media + DMSO control increased the level of PGE2
24-fold over media + DMSO control alone (0.08 ± 0.03 ng/mL for media + DMSO,
1.9 ± 0.3 ng/mL for media + DMSO + LPS). Extracts in the culture media without
LPS did not affect the concentration of PGE2 as compared to the media + DMSO
control. **, p value < 0.0001 as compared to control.
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ethanol extracts of Hp accessions were able to significantly
reduce LPS-induced PGE2 levels, albeit at higher concentrations
than in the Soxhlet chloroform extracts. Next, we tested both
the Soxhlet chloroform and Soxhlet ethanol extracts of four Hp
accessions at 8 íg/mL (Figure 1). Accession Elixir reduced
LPS-induced PGE2 levels in both the Soxhlet chloroform and
Soxhlet ethanol extracts. The other accessions exhibited little
anti-inflammatory activity at this dose.
The cytotoxicity of the NCRPIS Hp extracts was also
assessed. There was no significant difference between light-
activated and dark treatments for any of the Hp extracts, and
data were pooled across this variable. All Hp extracts tested at
their highest concentration produced significant cytotoxicity as
compared to the solvent control except for the Soxhlet chloro-
form Elixir extract at 8 íg/mL (Table 3). Reductions in PGE2
levels ranged from 89 to 93% and from 43 to 85% for Soxhlet
ethanol and chloroform extracts, respectively, whereas the
percent reductions in cell viability were 35-41 and 23-49%,
respectively. Therefore, some of the reduction in PGE2 may
have been due to cytotoxicity in the RAW264.7 macrophage
cells. However, none of the Hp extracts assayed at 8 íg/mL
produced statistically significant cytotoxicity (4-23% reduction
in cell viability in chloroform extracts, 23-28% reduction in
cell viability in ethanol extracts), suggesting that the anti-
inflammatory activity of accession Elixir at 8 íg/mL (43 and
47% reductions for chloroform and ethanol, respectively) was
not simply due to cytotoxicity of the cells (Table 4). To further
support this, no reductions in LPS-induced PGE2 levels were
observed with ‘Helos’, PI 371528, and ‘Topas’ at 8 íg/mL,
despite 17-22% reduction in cell viability, suggesting that this
range of cytotoxicity was not directly reflected in PGE2 levels
in this assay (Table 4).
To further evaluate the activities of these Hp extracts, dose-
response studies were conducted for Soxhlet ethanol extracts
of accessions Common, PI 371528, and Elixir. Soxhlet ethanol
extracts of accessions PI 371528 and Elixir showed a dose-
dependent inhibition of PGE2 at higher concentrations (Figure
2). At lower concentrations, only accession Elixir was able to
significantly reduce PGE2. Significant cytotoxicity was observed
for PI 371528 at 11.5, 15, and 30 íg/mL and for Elixir at 30
íg/mL (Table 4). Thus, some of the reductions in PGE2 levels
in these Soxhlet ethanol Hp accession extracts could be due to
cytotoxicity.
Anti-inflammatory Activity and Cytotoxicity of Constitu-
ents Identified within Hp Extracts. The anti-inflammatory
activity of constituents identified within Hp extracts (hyperforin,
quercetin, quercitrin, isoquercitrin, rutin, hyperoside, amentofla-
vone, chlorogenic acid, pseudohypericin, and hypericin) was
studied. Because there was no significant difference between
dark and light-activated treatments for most constituents, data
Table 2. Constituents Identified and Quantified within NCRPIS Hp Extractsa
compound concn (íM)
accession extract
chlorogenic
acid rutin
hypero-
side
isoquer-
citrin
quer-
citrin
quer-
cetin
amento-
flavone
pseudo
hypericin
hyperi-
icin
hyper-
forin
Common ethanol 25 ± 0.1 b 15 ± 0.02 b 5 ± 0.02 b 1 ± 0.01 b 0.2 ± 0.02 b 1 ± 0.02 c 0.5 ± 0.006 a 1 ± 0.05 c 0.2 ± 0.05 a 22 ± 0.05
chloroform − − − − 0.08 ± 0.02 a − detected − − 8 ± 0.05 c
PI 325351 ethanol 13 ± 0.5 a 13 ± 0.1 b 3 ± 0.03 a 0.5 ± 0.006 a 0.2 ± 0.02 b 0.5 ± 0.02 b 0.2 ± 0.06 a 0.5 ± 0.003 b 0.1 ± 2.5 a 11 ± 0.02 c
chloroform − − − − − − − − − 5 ± 0.04 b
PI 371528 ethanol 11 ± 0.4 a 8 ± 0.06 a 4 ± 0.02 ab 0.9 ± 0.01 b 0.1 ± 0.02 ab 0.2 ± 0.02 a 0.2 ± 0.06 a 0.3 ± 0.006 a 0.06 ± 3.9 a 17 ± 0.03 d
chloroform − − − − − − − − − 7 ± 0.01 bc
‘Helos’ ethanol 28 ± 0.2 b 13 ± 0.5 b 7 ± 0.03 c 2 ± 0.0006 c 0.3 ± 0.02 c 0.8 ± 0.02 c 2 ± 0.06 b 1 ± 0.01 c 0.4 ± 0.0005 b 70 ± 0.02 e
chloroform − − − − 0.07 ± 0.02 a − detected − − 6 ± 0.04 b
Elixir ethanol 25 ± 0.2 b 11 ± 0.03 b 7 ± 0.05 c 0.8 ± 0.01 b 0.2 ± 0.02 b 0.5 ± 0.02 b 0.7 ± 0.06a 0.7 ± 0.04 bc 0.6 ± 0.0004 c 11 ± 0.05 c
chloroform − − − − − − − − detected −
‘Topas’ ethanol 10 ± 0.1 a 9 ± 0.02 a 3 ± 0.06 a 0.4 ± 0.02 a 0.1 ± 0.02 ab 0.2 ± 0.02 a detected 0.2 ± 0.05 a 0.04 ± 0.005 a 8 ± 0.02 b, c
chloroform − − − − − − − − − 1 ± 0.04 a
a Compounds identified and quantified by LC-MS-UV analysis. Hp extracts were analyzed in the concentrated stock extract, and calculations were made to estimate the
concentration of constituents present in the amount of Hp extract used for treatment denoted as highest concentration tested in this paper. Ten metabolites from 12 Soxhlet
Hp extracts were quantified. The data are represented as mean concentration ± standard error. “Detected” indicates detection by the MS; however, the amount was too
low for quantification with the UV absorption data. “−” represents compounds not detected by the MS. Mean values within each column with different letters were significantly
different (a < b < c < d < e) (p < 0.05), and values with more than one letter were not significantly different from means sharing either of the letters.
Table 3. Anti-inflammatory Activity and Cytotoxicity of NCRPIS Accessions of Dried Hp Plant Material Tested To Represent the Relative Amount
Extracted from 6 g of Plant Material
chloroform ethanol
accession
[íg/mL]
testeda
% reduction in LPS-
induced PGE2b (95% CI)
% reduction in
cell viabilityc (±SE)
[íg/mL]
testeda
% reduction in LPS-
induced PGE2b (95% CI)
% reduction in
cell viabilityc (±SE)
Common 14 50 (7−74)* 35 ± 4* 73 91 (87−94)** 38 ± 5*
PI 325351 15 66 (36−82)* 41 ± 7** 147 93 (83−93)** 40 ± 6*
PI 371528 12 80 (62−89)** 49 ± 3** 65 93 (84−93)** 41 ± 7**
‘Helos’ 16 73 (49−85)* 49 ± 3** 181 93 (85−93)** 35 ± 2*
Elixir 8 43 (35−51)* 23 ± 11 122 89 (75−89)** 36 ± 4*
‘Topas’ 29 85 (73−92)** 32 ± 3* 110 92 (83−93)** 41 ± 4*
a The concentration tested in íg/mL represents the final concentration of the extract in the media. Anti-inflammatory activity [b mean percent reduction in LPS-induced
PGE2 levels as compared to media + LPS + DMSO control (95% confidence intervals)] and cytotoxicity (c mean percent reduction in cell viability as compared to media
+ DMSO control-treated cells ± standard error) of Hp extracts (n ) 8 for each). Data represent light-activated and dark treatments combined as there were no significant
differences between the light-activated and dark treatments for any of the extracts. Addition of LPS to the culture media + DMSO control increased the level of PGE2 36-fold
over media + DMSO control alone (0.16 ± 0.03 ng/mL for media + DMSO, 2.9 ± 0.22 ng/mL for media + DMSO + LPS). Extracts in the culture media without LPS did
not affect the concentration of PGE2 as compared to the media + DMSO control. *, p value < 0.05 as compared to control. **, p value < 0.0001 as compared to control.
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were pooled across this variable in Table 5. Pseudohypericin
and hypericin were the only constituents that displayed differ-
ences between dark and light-activated treatments and are
displayed in Figure 3. Hyperforin significantly decreased PGE2
levels at 40 and 80 íM. Quercetin significantly reduced PGE2
at 5-40 íM (Table 5). Quercitrin and isoquercitrin reduced
PGE2 levels at 5-20 íM. Rutin was the only flavonoid that
did not significantly reduce LPS-induced PGE2 levels at the
doses tested. Amentoflavone significantly reduced PGE2 levels
at 10 íM. Chlorogenic acid did not reduce PGE2 levels at
concentrations up to 40 íM. The range of concentrations of
the individual constituents tested for bioactivity spanned the
amounts detected in the extracts as tested at the highest
concentration for each extract (Table 2). Constituents that were
not detected within the extracts or detected at levels too low to
quantify were not included in this concentration range. Although
amentoflavone concentrations in the Hp extracts at their highest
concentration ranged from 0.2 to 2 íM, because 10 íM
amentoflavone was needed to significantly reduce PGE2 levels,
amentoflavone was not tested at concentrations below 1 íM.
The cytotoxicity of the constituents identified within Hp
extracts was also assessed. No significant differences between
light-activated and dark treatments were observed for constitu-
ents except for pseudohypericin and hypericin (Table 6 and
Figure 3A). Significant cytotoxicity was observed with 20 íM
isoquercitrin and hyperoside (40 and 35% reductions in cell
viability, respectively) (Table 5). However, 20 íM isoquercitrin
and hyperoside also significantly reduced PGE2 levels to a
greater extent (66 and 56% reductions, respectively) (Table 6),
suggesting that although there was cytotoxicity present at this
dose, it probably did not account for all of the reduction in PGE2.
Hypericin at 2 íM produced significantly greater cytotoxicity
in light-activated treatments than in the dark, with no reductions
in PGE2 (Table 6). Hypericin at 20 íM increased PGE2 levels
both with and without LPS in the light-activated condition
(Figure 3A). Hypericin at 20 íM produced significant cyto-
toxicity in light-activated conditions but not in the dark, and a
significant difference between light-activated and dark treat-
ments was observed (Table 6). Hypericin at 20 íM exhibited
86% reduction in cell viability while significantly increasing
PGE2 levels; thus, the increase in PGE2 by 20 íM hypericin
may have been attenuated by this cytotoxicity.
Pseudohypericin exhibited light-activated effects on both
PGE2 levels and cytotoxicity. When light-activated at 2 íM,
pseudohypericin slightly but significantly increased PGE2 levels
as compared to control when LPS was not added (Figure 3B).
Figure 1. Anti-inflammatory activity was screened using the PGE2 assay
(n ) 8 for each). Data are presented as mean LPS-induced PGE2 level
± standard error. Data represent light-activated and dark treatments
combined as there were no significant differences between light-activated
and dark treatments for each extract. Addition of LPS to the culture media
+ DMSO control increased the level of PGE2 20-fold over media + DMSO
control alone (0.1 ± 0.05 ng/mL for media + DMSO, 2.4 ± 0.3 ng/mL for
media + LPS + DMSO). Extracts in the culture media without LPS did
not affect the concentration of PGE2 as compared to the media + DMSO
control. /, p < 0.05, as compared to media + DMSO control.
Table 4. Cytotoxicitya of NCRPIS Soxhlet Ethanol Extracts of
Accessions Common, PI 371528, Elixir, ‘Helos’, and ‘Topas’
accession extract
[íg/mL]
testedb
% reduction in
cell viabilityc (±SE)
Common ethanol 30 30 ± 6
15 20 ± 9
11.5 16 ± 13
8 17 ± 10
PI 371528 ethanol 30 44 ± 8*
15 42 ± 6*
11.5 34 ± 13*
8 22 ± 3
PI 371528 chloroform 8 22 ± 10
Elixir ethanol 30 37 ± 3*
15 24 ± 8
11.5 25 ± 9
8 23 ± 10
5 18 ± 6
1 15 ± 11
Elixir chloroform 8 23 ± 11
‘Helos’ ethanol 8 23 ± 10
‘Helos’ chloroform 8 4 ± 8
‘Topas’ ethanol 8 27 ± 11
‘Topas’ chloroform 8 22 ± 10
a Cytotoxicity (b mean percent reduction in cell viability as compared to medium
+ DMSO control-treated cells ± standard error) of Hp extracts (n ) 8 for each).
c The concentration tested in íg/mL represents the final concentration of the extract
in the media. Data represent light-activated and dark treatments combined as there
were no significant differences between the light-activated and dark treatments for
any of the extracts. *, p value < 0.05 as compared to control.
Figure 2. Anti-inflammatory activity was screened using the PGE2 assay
(n ) 8 for each). Data are presented as mean LPS-induced PGE2 level
± standard error. Controls were the same for each accession tested and
are represented as a single bar. Elixir at 5 and 1 íg/mL did not significantly
reduce PGE2 levels as compared to control with values of 1.7 ± 0.3 and
2.1 ± 0.5, respectively (data not shown). Data represent light-activated
and dark treatments combined as there were no significant differences
between light-activated and dark treatments for each extract. Addition of
LPS to the culture media + DMSO control increased the level of PGE2
13-fold over media + DMSO control alone (0.1 ± 0.02 ng/mL for media
+ DMSO, 1.7 ± 0.2 ng/mL for media + LPS + DMSO). Extracts in the
culture media without LPS did not affect the concentration of PGE2 as
compared to the media + DMSO control. /, p < 0.05, as compared to
media + DMSO control.
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Pseudohypericin at 1 and 2 íM significantly reduced LPS-
induced PGE2 levels in light-activated but not dark treatments
(Figure 3B). Pseudohypericin at 0.02, 0.2, and 0.5 íM did not
alter PGE2 production without or with LPS. Pseudohypericin
at 1 and 2 íM produced significant cytotoxicity in light-activated
conditions, and there were significant differences between light-
activated and dark treatments for 1 and 2 íM pseudohypericin
(Table 6). The cytotoxicity of light-activated pseudohypericin
may have contributed to the reduction in PGE2 production in
the light-activated condition.
DISCUSSION
Many studies have assessed the anti-inflammatory activity
of Hp extracts both in cell culture and in vivo (4-8). These
previous studies usually examined one Hp extract made from
one extraction procedure and from a single accession of Hp.
The present paper expands upon the earlier studies; however,
because our work involved assessing anti-inflammatory activity
by only one assay, LPS-induced PGE2 production, other anti-
inflammatory endpoints must be studied to further extend these
observations. The identification of accessions and extraction
procedures that exhibit greater anti-inflammatory activity with
less cytotoxicity may lead to improved Hp botanical supple-
ments. Furthermore, although cytotoxicity and antiviral studies
are often performed in light-activated and dark treatment
conditions, the light dependence of the anti-inflammatory
activity of Hp extracts had not been studied. To our knowledge,
this is the first study demonstrating that the anti-inflammatory
activity of Hp extracts is light-independent.
The Hp accessions tested displayed different anti-inflamma-
tory activities at the highest concentrations tested with the
greatest inhibition of PGE2 production (93% reduction) with
Soxhlet ethanol accessions of PI 325351, PI 371528, and
‘Helos’, which may reflect the genetic background or devel-
opmental differences among accessions. Accession Elixir clearly
exhibited the greatest anti-inflammatory activity at lower
concentrations in both Soxhlet chloroform and Soxhlet ethanol
extractions. It is interesting that no differences were observed
between light-activated and dark treatments for anti-inflamma-
tory activity, contrary to previously reported results for antiviral
and other bioactivities (1, 12, 13, 19), suggesting that the
constituents present within Hp extracts that exerted anti-
inflammatory activity were not dependent on light activation.
Furthermore, both Soxhlet ethanol and Soxhlet chloroform Elixir
extracts exhibited similar anti-inflammatory activities at 8 íg/
mL, suggesting that the compounds responsible for anti-
inflammatory activity may be extracted in both ethanol and
chloroform. However, the only common constituent that was
detected by LC-MS-UV analysis in both of the Elixir extracts
was hypericin. Hypericin tested as a pure constituent did not
reduce PGE2 levels, suggesting that unknown compounds within
these two extracts may explain the greater anti-inflammatory
activity of Elixir.
Because hypericin has been shown to inhibit 12-lipoxygenase
(20) and inhibit the release of arachidonic acid in human
granulocytes (21), treatments with hypericin were performed
to determine the effect of light activation on anti-inflammatory
activity. Hypericin showed no reduction in LPS-induced PGE2
levels as compared to controls in light-activated or dark
treatments up to concentrations of 20 íM. Because hypericin
concentrations between 0.05 and 0.2 íM would be present in
the highest concentration of extract tested, it is unlikely that
hypericin present within the Hp extract was reducing PGE2
levels. The concentration of pure hypericin needed to observe
an effect was 20 íM, but this was a pro-inflammatory effect,
and this dose was significantly cytotoxic to the cells. This is
the first report of hypericin’s effect on PGE2 levels in LPS-
induced RAW264.7 macrophages.
Pseudohypericin displayed light-activated properties. Pseudo-
hypericin reduced PGE2 with LPS and increased PGE2 without
LPS. In a lipoxygenase activity assay, pseudohypericin inhibited
12-lipoxygenase, although light conditions were not described
(20). These results support the role of pseudohypericin as an
anti-inflammatory compound in stimulated cells, although data
from Hp extracts presented here suggest that compounds
responsible for the anti-inflammatory activity of extracts were
not light-activated. The concentration of pseudohypericin needed
to observe an anti-inflammatory effect was 1 íM, whereas the
concentration of pseudohypericin present in the highest con-
centration of extract tested was 0.3-1 íM; thus, it is possible
that pseudohypericin contributed at least to some extent to the
anti-inflammatory activity of Hp extracts.
Table 5. Anti-inflammatory Activitya and Cytotoxicity of Constituents
Identified within Hp Extracts
class constituent concn (íM)
% reduction
in LPS-
induced
PGE2b(95% CI)
% reduction
in cell
viabilityc
(±SE)
phloroglucinol hyperforin 0.02, 2, 5, 10 0 (0−36) 3 ± 8
20 14 (0−43) 22 ± 6
40 48 (22−66)* 28 ± 4
80 62 (43−75)* 34 ± 11
flavonoid quercetin 0.2, 2 0 (0−52) 0 ± 4
5 66 (21−85)* 1 ± 13
10 87 (78−92)** 14 ± 15
20 93 (84−97)** 29 ± 12
40 96 (90−98)** 33 ± 11
quercitrin 0.02, 0.2 0 (0−60) 0 ± 4
2 36 (0−72) 3 ± 8
5 54 (11−77)* 9 ± 9
10 67 (35−83)* 18 ± 20
20 71 (22−87)* 33 ± 15
isoquercitrin 0.02 0 (0−47) 0 ± 5
0.2 9 (0−53) 0 ± 12
2 31 (0−64) 13 ± 7
5 60 (8−83)* 22 ± 12
10 62 (23−85)* 23 ± 13
20 66 (43−94)* 40 ± 8*
rutin 0.2, 2, 5 0 (0−41) 0 ± 12
10 7 (0−57) 17 ± 8
20 17 (0−59) 18 ± 7
40 24 (10−60) 19 ± 16
hyperoside 0.2 8 (0−33) 22 ± 20
2 27 (0−63) 29 ± 10
5 42 (0−70) 33 ± 17
10 51 (5−75)* 37 ± 13
20 56 (15−78)* 35 ± 6*
biflavonoid amentoflavone 1 38 (0−73) 8 ± 4
5 53 (0−79) 13 ± 5
10 77 (46−90)* 15 ± 14
other chlorogenic acid 1, 5, 10, 20, 40 0 (0−54) 0 ± 6
a Anti-inflammatory activity [b mean percent reduction in LPS-induced PGE2 level
as compared to media + LPS + DMSO control (95% confidence intervals)] and
cytotoxicity (c mean percent reduction in cell viability as compared to media +
DMSO control-treated cells ± standard error) (n ) 8 for anti-inflammatory treatments;
n ) 8 for cytotoxicity treatments) of pure compounds identified within Hp extracts
on RAW264.7 macrophage cells. Data represent light-activated and dark treatments
combined as there was no significant difference between light-activated versus
dark treatments. Pure compounds in the culture media without LPS did not affect
the concentration of PGE2 as compared to the media + DMSO control. Addition
of LPS to the culture media + DMSO control increased the level of PGE2 15−
35-fold over media + DMSO control alone. *, p value < 0.05 as compared to
control. **, p value < 0.0001 as compared to control.
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Hyperforin inhibited LPS-induced PGE2 levels at 40 and 80
íM. The hyperforin concentration in Hp extracts at the highest
concentration tested was 1-70 íM. Therefore, higher concen-
trations of hyperforin may be contributing to the anti-inflam-
matory activity of Hp extracts. Albert et al. showed that
hyperforin suppressed COX-1 product formation with an IC50
of 0.3 íM for thrombin-stimulated or of 3 íM for ionophore-
stimulated human monocytic MM6 (Mono Mac 6) cells, but
hyperforin had no effect on COX-2 protein levels in LPS-
stimulated MM6 cells (22). This is the first report of hyperforin’s
effects in RAW264.7 macrophage cells.
Similar to our results with flavonoids, 40 and 80 íM quercetin
significantly decreased LPS-induced PGE2 levels in RAW264.7
macrophage cells while decreasing COX-2 protein at 80 íM
(23). Furthermore, rutin had no effect on LPS-induced PGE2
levels or COX-2 protein levels in RAW264.7 macrophages at
40 and 80 íM (23). Chlorogenic acid at 1-40 íM had no
significant effect on LPS-induced PGE2 levels, and 10 íM
chlorogenic acid would be present in the Hp extracts at the
highest concentration tested. Chlorogenic acid had no effect on
LPS-induced PGE2 levels in J774 macrophages up to 100 íM
(24).
Although cytotoxicity was observed at the highest concentra-
tion tested for all the Hp extracts except for the Soxhlet
chloroform Elixir, no significant cytotoxicity was observed at
8 íg/mL for the Hp accession extracts. However, the extracts
did possess some moderate cytotoxicity that was not statistically
significant. The reduction in PGE2 for both the Hp extracts and
constituents cannot be explained by cytotoxicity alone as
evidenced by the Hp extracts at lower doses and the constituents,
and in agreement with Schmitt et al. the Hp extracts exhibited
light-independent cytotoxicity, whereas the naphthodianthrones
had light-dependent cytotoxicity (12).
In conclusion, Hp extracts possessed anti-inflammatory
activity that varied with extraction solvent and accession. The
profiles of known chemical constituents, flavonoids, bifla-
vonoids, phloroglucinols, and naphthodianthrones, varied among
the different accessions tested. Accession Elixir displayed the
most anti-inflammatory activity at lower concentrations; both
Soxhlet ethanol and Soxhlet chloroform extracts were active at
a concentration of 8 íg/mL. The cytotoxicity of Elixir at 8 íg/
mL was not statistically significant and cannot solely account
for the reductions in PGE2. Finally, flavonoids, biflavonoids,
phloroglucinols, and pseudohypericin were present within the
Figure 3. Anti-inflammatory activity (mean PGE2 level ± standard error) of hypericin and pseudohypericin was screened using the PGE2 assay (n ) 4).
Addition of LPS to the culture media + DMSO control increased the level of PGE2 12-fold over media + DMSO control alone (0.18 ± 0.09 ng/mL for
media + DMSO, 2.1 ± 0.3 ng/mL for media + LPS + DMSO) for pseudohypericin and 18-fold (0.17 ± 0.02 ng/mL for media + DMSO, 3.0 ± 0.6 ng/mL
for media + DMSO + LPS) for hypericin. /, p < 0.05, as compared to media + DMSO or media + LPS + DMSO control. #, p < 0.05, significant difference
between light-activated and dark treatments for corresponding dose.
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extracts and possessed significant anti-inflammatory activity;
however, the concentrations of these constituents in the Hp
extracts at the highest concentration tested were far less than
the concentration of pure constituent needed to observe a
significant anti-inflammatory effect, with the exception of light-
activated pseudohypericin at 1 íM in two of the Hp extracts
and hyperforin at 70 íM in one of the Hp extracts. Thus, the
anti-inflammatory activity of Hp extracts cannot be explained
by the presence of these constituents alone. Because Hp extracts
showed light-independent anti-inflammatory activity, it is likely
that interactions among identified and unidentified compounds
account for the diverse activities seen in different accessions
of Hp.
ABBREVIATIONS USED
Hp, Hypericum perforatum; PI, Plant Introduction; FNPC,
Frontier Natural Products Co-op; NCRPIS, North Central
Regional Plant Introduction Station; PGE2, prostaglandin E2;
LPS, lipopolysaccharide.
SAFETY
Organic solvents, such as hexane and chloroform, are toxic
chemicals and should be properly handled in a fume hood.
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